Fast Titration in the Treatment of Schizophrenia, Taiwan
Phase 3
Completed
- Conditions
- Schizophrenia
- Registration Number
- NCT00304473
- Lead Sponsor
- AstraZeneca
- Brief Summary
Assess the efficacy of a fast titration of quetiapine to the current titration approved by the regulatory authorities.
PLEASE NOTE: Seroquel SR and Seroquel XR refer to the same formulation. The SR designation was changed to XR after consultation with FDA.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
- Signed informed consent, at least 18 years old, inpatients with relapse Schizophrenia all subtypes, and with a CGI (Clinical Global Impression) score >=4.
Exclusion Criteria
- Pregnancy or breast-feeding, patients treated with Clozapine within 28 days of randomization, patients with a known arrhythmia, any psychotic disorders not defined in the inclusion criteria.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Compare the safety and tolerability of a fast titration of quetiapine to the current titration approved by the regulatory authorities.
- Secondary Outcome Measures
Name Time Method Assess the efficacy of a fast titration of quetiapine to the current titration approved by the regulatory authorities.
Trial Locations
- Locations (1)
Research Site
🇨🇳Taoyuan, Taiwan